Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Angelo J. Cambio"'
Autor:
Angelo J. Cambio, Richard M. Roach, Paul Arnold, Joseph Cambio, Clifford D. Gluck, Sean P. Heron
Publikováno v:
Advances in Urology, Vol 2022 (2022)
Purpose. This US FDA investigational device exemption (IDE) study evaluated the extended use of The Spanner® Temporary Prostatic Stent in catheter-dependent men with urinary retention who were not deemed candidates for corrective surgery but demonst
Externí odkaz:
https://doaj.org/article/f5e80335254a44f8b3f4c5e5d150645d
Autor:
Angelo J. Cambio, Richard M. Roach, Paul Arnold, Joseph Cambio, Clifford D. Gluck, Sean P. Heron
Publikováno v:
Advances in Urology, Vol 2022 (2022)
Purpose. This US FDA investigational device exemption (IDE) study evaluated the extended use of The Spanner® Temporary Prostatic Stent in catheter-dependent men with urinary retention who were not deemed candidates for corrective surgery but demonst
Autor:
Primo N. Lara, Gurkamal Chatta, Przemyslaw Twardowski, Karen G. Chee, Jacek Pinski, David R. Gandara, Chong-Xian Pan, Jeff Longmate, David I. Quinn, Angelo J. Cambio, Christopher P. Evans
Publikováno v:
Clinical Genitourinary Cancer. 5:433-437
Perifosine is an oral alkylphospholipid that inhibits cancer cell growth through decreased Akt phosphorylation. We conducted a phase II trial of perifosine in patients with biochemically recurrent, hormone-sensitive prostate cancer.Eligible patients
Autor:
Christopher P. Evans, Angelo J. Cambio
Publikováno v:
Therapeutics and Clinical Risk Management
Therapeutics and clinical risk management, vol 3, iss 1
Therapeutics and clinical risk management, vol 3, iss 1
Author(s): Cambio, Angelo J; Evans, Christopher P | Abstract: BackgroundBenign prostatic hyperplasia (BPH) is a common disease of the aging male population. BPH treatment includes a variety of pharmacological and surgical interventions. The goal of t
Autor:
Primo N. Lara, Joy C. Yang, Christopher P. Evans, Joon-Ha Ok, Angelo J. Cambio, Eric C. Nelson
Publikováno v:
Prostate Cancer and Prostatic Diseases. 10:6-14
The cellular signaling pathways of the prostate play a central role in the induction, maintenance, and progression of prostate cancer (CaP). Neuroendocrine (NE) cells demonstrate attributes that suggest they are an integral part of these signaling ca
Autor:
Christopher P. Evans, Angelo J. Cambio
Publikováno v:
BJU International. 97:456-460
Publikováno v:
Current Opinion in Urology. 15:342-349
PURPOSE OF REVIEW Metastatic or unresectable urothelial cancer of the urinary bladder has traditionally been treated with systemic chemotherapy, which is most often platinum-based. The long-term survival data and the associated toxicities from this f
Publikováno v:
Journal of Urology. 183
Publikováno v:
BJU international. 101(7)
OBJECTIVES To better define the outcome and association of multicystic dysplastic kidney (MCDK) with hypertension, vesico-ureteric reflux (VUR), infection and cancer, as there is no consensus on the management of patients born with MCDK. The risk of
Autor:
Angela DiGrande, Angelo J. Cambio, Eric A. Kurzrock, Stacy T. Tanaka, Thuan Nguyen, Dana K. Nanigian
Publikováno v:
The Journal of urology. 180
Fecal incontinence and constipation in children with spina bifida are recognized to impact quality of life. Most disease specific quality of life instruments on fecal incontinence target adults and/or children without neuropathic bowel. We developed